CREATIVE BIOMART INC

Creative Biomart Inc. specializes in advanced biotechnological research and laboratory services, with core expertise in molecular biology, gene expression analysis, and phage production for biomedical applications. The company delivers targeted research on plant transcription factors that regulate disease resistance pathways, alongside high-precision small RNA library preparation and next-generation sequencing of extracellular vesicles. Their technical capabilities include large-scale bacterial fermentation for M13 phage pellet harvesting, demonstrating proficiency in scalable microbial culture systems and downstream purification workflows. Creative Biomart distinguishes itself through its focus on functional genomics and molecular diagnostics, applying rigorous biochemical and virological methods to support agricultural and defense-related biosecurity initiatives. The contractor has established a consistent track record with the U.S. Department of Agriculture, providing research services focused on crop-pathogen interactions and molecular profiling of non-coding RNA in plant systems. Additionally, they have delivered biotechnological development work for the Department of Defense, specifically in phage-based biomanufacturing relevant to biothreat countermeasures. These engagements reflect a pattern of supporting mission-critical biological research with translational applications in food security and defense biosciences. Creative Biomart operates primarily under NAICS 541714, conducting non-nanobiotechnology research in biotechnology, and NAICS 541380, offering specialized laboratory testing services including nucleic acid sequencing and sample preparation. Their market positioning centers on niche biotech R&D for public sector clients requiring validated, reproducible molecular biology workflows with direct application to agricultural resilience and biodefense. As a small business structured as a 2L entity based in Shirley, New York, Creative Biomart Inc. maintains a focused operational footprint without federal certifications. Their government market presence is defined by direct, project-based engagements with federal science and research agencies, positioning them as a specialized contractor for precision biotechnology tasks requiring technical rigor and laboratory scalability.